TY - JOUR
T1 - Incidence and significance of pacemaker and implantable cardioverter-defibrillator lead masses discovered during transesophageal echocardiography
AU - Downey, Brian C.
AU - Juselius, Whitney E.
AU - Pandian, Natesa G.
AU - Estes, N. A.Mark
AU - Link, Mark S.
N1 - Copyright:
Copyright 2013 Elsevier B.V., All rights reserved.
PY - 2011/6
Y1 - 2011/6
N2 - Background: Pacemaker and implantable cardioverter-defibrillator device infections are feared complications. The finding of a lead-associated mass on transesophageal echocardiogram (TEE) raises concern for endocarditis. However, the incidence and clinical importance of lead masses is not currently known. Methods: Consecutive patients with transvenous leads undergoing TEE from July 1, 2003, to June 30, 2005, were identified and assessed for a clinical diagnosis of endocarditis. An echocardiographer blinded to clinical information reviewed all TEEs. Results: Of 177 TEEs performed on 153 patients, a visible mass on a device lead was observed in 25 (14%), including 11 TEEs showing a lead vegetation, 13 TEEs showing lead strands, and one study showing both. Seventeen patients were adjudicated to have endocarditis, of which eight had a mass seen on a lead during TEE. Thus, 72% of patients (18 of 25) with a lead-associated mass did not have evidence of an infection. In TEEs performed for indications other than to rule out endocarditis, lead masses were seen in 13 of 136 studies (10%), with only one patient adjudicated to clinically have an infected device. Conclusion: During this 2-year study of consecutive patients with a tranvenous lead undergoing TEE, lead-associated masses were found in 14% of patients. In 72% of patients, the mass did not prove to be secondary to infectious causes. Thus, masses attached to a device lead should be interpreted in the overall clinical context and, in the absence of concomitant evidence of endocarditis, should not mandate device and lead removal.
AB - Background: Pacemaker and implantable cardioverter-defibrillator device infections are feared complications. The finding of a lead-associated mass on transesophageal echocardiogram (TEE) raises concern for endocarditis. However, the incidence and clinical importance of lead masses is not currently known. Methods: Consecutive patients with transvenous leads undergoing TEE from July 1, 2003, to June 30, 2005, were identified and assessed for a clinical diagnosis of endocarditis. An echocardiographer blinded to clinical information reviewed all TEEs. Results: Of 177 TEEs performed on 153 patients, a visible mass on a device lead was observed in 25 (14%), including 11 TEEs showing a lead vegetation, 13 TEEs showing lead strands, and one study showing both. Seventeen patients were adjudicated to have endocarditis, of which eight had a mass seen on a lead during TEE. Thus, 72% of patients (18 of 25) with a lead-associated mass did not have evidence of an infection. In TEEs performed for indications other than to rule out endocarditis, lead masses were seen in 13 of 136 studies (10%), with only one patient adjudicated to clinically have an infected device. Conclusion: During this 2-year study of consecutive patients with a tranvenous lead undergoing TEE, lead-associated masses were found in 14% of patients. In 72% of patients, the mass did not prove to be secondary to infectious causes. Thus, masses attached to a device lead should be interpreted in the overall clinical context and, in the absence of concomitant evidence of endocarditis, should not mandate device and lead removal.
KW - Pacemaker
KW - defibrillator
KW - endocarditis
KW - implantable
KW - transvenous leads
UR - http://www.scopus.com/inward/record.url?scp=79958112100&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79958112100&partnerID=8YFLogxK
U2 - 10.1111/j.1540-8159.2011.03034.x
DO - 10.1111/j.1540-8159.2011.03034.x
M3 - Article
C2 - 21303389
AN - SCOPUS:79958112100
SN - 0147-8389
VL - 34
SP - 679
EP - 683
JO - PACE - Pacing and Clinical Electrophysiology
JF - PACE - Pacing and Clinical Electrophysiology
IS - 6
ER -